After ROP Treatment: Eye Redness, Swelling and the Follow-Up Retinal Examinations Ahead

The laser took less than an hour. When the nurse wheels the isolette back to its corner of the unit, the baby inside looks slightly different: eyelids pink and swollen, a smear of ointment at the lashes, pupils still enormous from the dilating drops. A parent who has spent eleven weeks learning the sound of every monitor now has a new thing to watch, and no idea what normal looks like.

That gap is the reason for this piece. After ROP treatment, what to expect is rarely explained in one sitting, because the ophthalmologist is speaking to a family who has just heard the words “laser” and “retina” about a baby weighing less than a bag of sugar. The information lands in fragments.

So here it is in one place: why the eyes look the way they do, how long the surface changes usually persist, what the retina is doing underneath, and why the examinations keep coming long after the procedure is over.

After ROP treatment, what to expect in the first 48 hours

Retinopathy of prematurity, or ROP, is a condition in which blood vessels grow abnormally in the retina, the light-sensing layer at the back of the eye, in babies born very early. Treatment aims to stop that abnormal growth before it pulls the retina out of place. In the hours afterward, the baby is back in the neonatal unit, and what you see is mostly the surface of the eye reacting to what was done to it.

Expect the eyelids to be swollen, sometimes enough that the eye stays closed for a while. The white of the eye is often red. After a laser procedure the redness tends to be diffuse; after an injection there may be a bright, sharply bordered blood spot near where the needle passed. Both are described by the National Eye Institute and Cleveland Clinic as common effects of treatment and examination rather than complications in themselves.

The pupils will stay wide because dilating drops, which relax the muscle that narrows the pupil so the retina can be seen, wear off over hours rather than minutes. A baby with wide pupils is more light sensitive, and nurses will usually keep lighting low.

The eye team typically prescribes drops or ointment for a set number of days. These are commonly an antibiotic to reduce infection risk, an anti-inflammatory, or both. The type, timing and duration belong to the prescribing ophthalmologist; parents are usually taught how to help hold the baby steady rather than how to give them.

Babies who had general anesthesia or sedation may feed slowly or sleep more deeply for the first day. The neonatal team monitors breathing and heart rate closely during this window, which is one reason treatment is done in or near the unit.

What ROP treatment actually does to the retina

The retina normally finishes growing its blood supply in the last weeks before a full-term birth. A baby born at 26 weeks arrives with a large rim of retina that has no vessels yet. In the outside world, with different oxygen levels and without the placenta’s growth signals, that vessel growth can stall and then restart in a disorganized way.

The engine behind the disorganized growth is a protein called vascular endothelial growth factor, or VEGF, which tells blood vessels to grow. Retina without a blood supply is starved of oxygen and releases large amounts of VEGF. Instead of orderly vessels spreading toward the edge, the eye grows a ridge of fragile new vessels that can leak, form scar tissue and, in the worst case, contract and pull the retina away from the wall of the eye.

Laser treatment addresses this by placing hundreds of tiny burns across the retina that has no vessels. That tissue is no longer starved, so it stops sending out the VEGF signal, and the abnormal vessels typically shrink back. The peripheral retina that was treated does not recover its function, which is why treatment is reserved for eyes at real risk.

Anti-VEGF treatment takes a different route. A medicine from the anti-VEGF class is injected into the jelly of the eye, where it binds the excess VEGF directly. This can allow normal vessel growth to resume toward the edge, but the effect is temporary and the disease can return once the drug wears off, so watching continues for longer.

The evidence that early treatment helps comes from the Early Treatment for Retinopathy of Prematurity study, which found that treating eyes with high-risk disease sooner reduced unfavorable structural outcomes from 15.6% to 9.1% at nine months (PubMed, ETROP 2003).

What is considered severe ROP, and who is usually asked to wait?

Ophthalmologists describe ROP using three coordinates. Zone is how close to the center of the retina the disease sits; zone I is the innermost and most dangerous. Stage, from 1 to 5, describes how abnormal the vessel growth is, with stage 4 meaning a partial retinal detachment and stage 5 a total one. Plus disease means the vessels near the center are dilated and twisted, a sign the process is active and fast.

Severe ROP, in the sense that triggers treatment, is usually what the ETROP study labeled type 1 disease (PubMed, ETROP 2003). It includes any stage of ROP in zone I with plus disease, stage 3 in zone I without plus disease, and stage 2 or 3 in zone II with plus disease. These eyes are typically treated within days of the finding, because the window between plus disease and detachment can be short.

Type 2 ROP, such as stage 3 in zone II without plus disease, is the group usually asked to wait. Waiting is not neglect. Most ROP regresses on its own as the baby matures, and the ETROP data showed that treating type 2 eyes did not improve outcomes enough to justify the loss of peripheral retina. These babies are examined more often instead, so any shift toward type 1 is caught.

A related term, aggressive ROP, describes a rapidly progressing form usually seen in the smallest babies, where the tidy stage sequence may be skipped. It is treated as urgently as type 1.

If you were told your baby had “stage 3 with plus,” that is the middle of the type 1 definition, and treatment was in line with mainstream practice. If you were told to come back in a week, the team judged the eye was still in the watching group.

Why the eyes look red and puffy after ROP laser or injection

Almost everything visible on the surface after treatment traces back to one of four things: the speculum, the depressor, the laser energy or the needle.

A speculum is a small wire device that holds the eyelids open. In a baby whose lids are thin and easily bruised, it leaves the lid margins pink and swollen. Scleral depression, in which the examiner gently presses on the outside of the eye with a blunt instrument to bring the far edge of the retina into view, adds to that swelling and can leave a little redness on the white of the eye. Both happen during ordinary screening exams too, which is why your baby’s eyes may have looked slightly irritated after earlier checks.

Laser adds heat. The energy is aimed at the retina, but the tissues in front of it absorb a fraction, and the conjunctiva, the clear membrane over the white of the eye, responds by becoming inflamed and puffy. Eyelid swelling after laser is often more pronounced than after an injection for this reason.

An injection leaves a subconjunctival hemorrhage, a flat bright-red patch where a tiny vessel bled under the clear membrane. It looks alarming and is usually painless; it fades through yellow the way any bruise does.

None of these surface changes tells you anything about whether the retina is responding. That information only comes from the follow-up examination. The care team will tell you the range of days over which they expect the swelling and redness to settle for your baby; if things move in the other direction, with increasing swelling, discharge or a lid that becomes hot and hard, that is a reason to speak to them the same day.

Laser versus anti-VEGF injection for ROP: what the aftermath looks like

Families are sometimes told which treatment was used without being told why, or why the follow-up plan differs. The two approaches leave different footprints, and the table below summarizes what mainstream evidence describes.

Aspect	Laser	Anti-VEGF injection
Where it acts	Peripheral retina without vessels	The VEGF protein inside the eye
Anesthesia	Usually general anesthesia or deep sedation	Often local anesthesia with sedation or comfort measures
Surface appearance	Diffuse redness, more lid swelling	Localized blood spot at injection site
Timing of recurrence in BEAT-ROP (PubMed 2011)	Mean about 6 weeks after treatment	Mean about 16 weeks after treatment
Recurrence needing retreatment in BEAT-ROP	26% of eyes	6% of eyes
Length of intensive follow-up	Shorter once regression confirmed	Longer, because late recurrence is possible
Peripheral vision	Treated retina is permanently lost	Peripheral retina may continue to develop vessels
Long-term concern flagged by NEI	Higher rates of nearsightedness	Uncertainty about effects on the developing body

The BEAT-ROP trial compared the two approaches in babies with zone I or posterior zone II stage 3 plus disease. Its headline numbers favored the injection on recurrence, but the trial was small, the laser recurrence rate was higher than in some other series, and it was not designed to measure long-term development. Later reviews have not settled the question of whether an anti-VEGF drug that leaves the eye and enters the bloodstream affects a premature baby’s brain or lungs. The evidence so far is reassuring on some measures and unclear on others.

That uncertainty is why choice of treatment sits with the treating ophthalmologist and neonatologist, who weigh the zone of disease, the baby’s ability to tolerate anesthesia and the family’s ability to return for prolonged follow-up. Neither option is the “better” one in the abstract.

Feeding, sleep and comfort in the days after ROP treatment

A premature baby cannot tell you the eye aches. What the neonatal team relies on instead are structured pain scores, which combine facial expression, cry, body tension, heart rate and oxygen saturation into a number checked at intervals. Parents often notice the signs before the score does: a furrowed brow, a stiffened body, a baby who was settling well at feeds and is now fussing.

Comfort measures matter here and are within a parent’s reach. Skin-to-skin holding lowers stress hormones and steadies breathing in premature infants, and most units encourage it once the baby is stable after anesthesia. Swaddling with the hands near the face, offering a pacifier, keeping voices low and lights dim, and clustering handling so the baby is disturbed less often are all standard developmental-care practices.

Feeding may be slower for a day or two, especially if the baby was intubated for a laser procedure. Some units pause oral feeds briefly around anesthesia and restart by tube; this is a routine safety step, not a sign that anything went wrong. A baby who was learning to breastfeed or bottle-feed may need a few days to regain the rhythm.

Eye drops or ointment are usually the part parents worry about most. Warm the tube in your hand for a moment, hold the baby securely, and let the nurse show you the technique; the goal is a calm baby, not speed. If the schedule or the medicine itself raises questions, they go to the prescribing team rather than the internet.

Pain relief after treatment is decided by the neonatal team based on the scores. Decisions about any medicine, including whether one is needed at all, belong to them.

The ROP follow-up schedule: how often are the retinal examinations?

Treatment does not end the watching. The abnormal vessels need to be seen shrinking, and the team needs to know they are not regrowing.

Before treatment, babies at risk are examined roughly every one to three weeks depending on findings, according to the National Eye Institute. After treatment, the interval usually tightens. Many teams re-examine within the first week and then weekly until the vessel ridge is clearly flattening and plus disease has gone. Once regression is well established, examinations space out to every few weeks, then months.

The end point differs by treatment. After laser, once the retina is stable, active ROP surveillance can wind down and hand over to routine pediatric eye care. After an anti-VEGF injection, the BEAT-ROP data showing recurrence at a mean of about 16 weeks means the team keeps looking for longer, often until the retina has grown vessels to its edge or the baby is well past the age at which recurrence has been reported (PubMed, BEAT-ROP 2011). Postmenstrual age, the baby’s gestational age plus weeks since birth, is the clock the team uses for this.

What the exam involves is familiar by now: dilating drops, a speculum, an indirect ophthalmoscope worn on the examiner’s head, and sometimes a wide-angle camera that photographs the retina so images can be compared week to week. Some units use remote reading of these images between in-person visits.

Parents can ask for a written plan. A dated list of upcoming checks, with the reason for each, makes it far easier to keep appointments after discharge. Missed follow-up in this window is one of the most preventable causes of poor outcome, because recurrence caught early can be retreated.

When does ROP go away? Regression, reactivation and the window of watching

“Go away” has two meanings for ROP, and separating them helps.

The first is regression. In most babies who are screened, ROP never reaches the treatment threshold; the abnormal vessels quietly shrink as the retina matures and normal vessels reach the edge. MedlinePlus and Johns Hopkins both describe this as the usual course of mild disease. Regression after treatment is the same process with help: the ridge flattens, the dilated central vessels return to normal caliber, and over subsequent weeks the examiner sees the disease burning out.

The second meaning is the risk period closing. Active ROP is a disease of the developing retina, and once the retina has finished developing, new disease does not start. For laser-treated eyes that have regressed, the team can often declare active surveillance complete within a few months of treatment. For anti-VEGF-treated eyes, the window stays open longer because the drug’s effect fades and the retina may still lack vessels at its edge.

Reactivation is the word for disease that returns after appearing to settle. It is why the exams continue. Signs the examiner watches for are the return of plus disease, new vessel growth at the ridge or new bleeding. If reactivation happens, retreatment with laser, a further injection or both is common, and the same rules about type 1 disease apply.

What does not go away is the record. A child treated for ROP is, in the eyes of every future optometrist and ophthalmologist, a child with a history that changes the schedule of routine care. That is not the disease persisting; it is sensible surveillance for the consequences described in the next sections.

If the retina detaches: how long does recovery take, and what happens next?

Retinal detachment is the outcome treatment is trying to prevent, and it still happens in a minority of treated eyes and in eyes where ROP was found late. Stage 4 means part of the retina has lifted; stage 5 means all of it has, often folding into a funnel shape behind the lens.

Surgery for a detached retina in a baby is different from the same operation in an adult. The options are a scleral buckle, a silicone band placed around the outside of the eye to push the wall inward against the retina, and a vitrectomy, in which the surgeon removes the jelly and scar tissue that are pulling on the retina from inside. Both are performed under general anesthesia by surgeons who specialize in pediatric retina.

Families searching “how long does it take to fully recover from a detached retina” will mostly find adult answers. For a baby, the honest response is that the surgical wound heals over weeks, but the retina’s function is measured over years, as the visual system develops. Some reattached retinas support useful vision; some support only light perception. Scarring at the center of the retina, and the degree to which the detachment reached the macula, the area responsible for detailed vision, shape the outcome more than the operation itself.

The team will not be able to promise a result, and a good team will say so. Questions worth asking are what the surgeon expects the eye to be able to do, whether a second operation is likely, and how the eye will be protected while it heals. A baby with one detached retina and one healthy eye has a different future from a baby with two, and care planning reflects that.

Retinopathy of prematurity long-term effects: glasses, squint and the years ahead

The National Eye Institute lists the later problems a child treated for ROP is more likely to face: nearsightedness, misaligned eyes, lazy eye, glaucoma and retinal detachment in later life. Each is manageable when it is looked for.

Nearsightedness, or myopia, is the most common. An eye treated with laser is particularly prone to becoming strongly nearsighted, partly because the treated peripheral retina changes how the eye grows. Glasses in the first two years are not unusual and are not a sign that treatment failed; they are a sign the child’s brain is being given a sharp image to learn from.

Strabismus, the medical word for a squint or misaligned eyes, occurs more often in premature children in general and more still after ROP. Left alone, the brain may begin to ignore the input from one eye, which leads to amblyopia, reduced vision in an otherwise healthy eye because it was not used during the years vision is being wired. Patching the stronger eye or blurring it with drops are the standard approaches, timed by the pediatric ophthalmologist.

Glaucoma, raised pressure inside the eye, is rarer but can arise years later, especially in eyes with significant scarring. Retinal tears and detachment can occur in adolescence or adulthood at the border between treated and untreated retina. Neither has warning signs a parent can reliably spot, which is why lifelong periodic examination is the standard advice from Johns Hopkins and the NEI.

None of this means a childhood spent in clinics. Once the active phase is over, most children are seen once or twice a year, more often only if a specific problem is being treated.

Is ROP a disability? Vision, development and support

The direct answer is that ROP itself is a diagnosis, and disability depends on what vision the child ends up with. Many children treated for ROP see well enough, with glasses, to attend mainstream school without visual adaptations. Some have reduced vision in one eye and normal vision in the other. A smaller number have low vision in both eyes, and a smaller number still are blind. MedlinePlus notes that severe ROP remains one of the leading causes of childhood visual impairment, which reflects the untreated and late-treated end of that spectrum.

Whether a child qualifies for a formal disability designation, educational support or early-intervention services depends on the measured vision and on local criteria, not on the ROP label. What matters practically is that a child whose vision is limited is identified early, because the systems that help, from high-contrast toys in infancy to enlarged print or orientation training later, work best when they start young.

Premature babies who needed ROP treatment were, by definition, among the smallest and sickest in the unit, and they are also at higher risk of the other consequences of extreme prematurity, including delays in motor skills and language. Developmental follow-up clinics exist for this reason, and eye findings feed into them. A child who is slow to reach for objects may be delayed, may not be seeing them, or both; the two teams need to talk.

Language shapes how a family experiences this. “Visually impaired” describes a measurement. It does not describe a child’s curiosity, humor or future. Parents who have been through it often say the most useful thing a clinician did was describe what the child could see, not only what the child could not.

What people often get wrong about life after ROP treatment

“The laser fixed it, so we are done.” Treatment changes the odds; it does not close the case. Reactivation is possible, and later effects on vision are common enough that the follow-up plan is part of the treatment, not an optional extra.

“Red eyes mean infection.” Redness and lid swelling are expected after both laser and injection. Infection inside the eye after an injection is rare and serious, but it looks different: a lid that is hot, hard and increasingly swollen, pus, a cloudy cornea or a baby who is unusually unsettled. The default explanation for redness on day one is the procedure.

“Oxygen caused it, so oxygen is dangerous.” Early studies did link unrestricted oxygen to ROP, and modern units target saturation ranges carefully. Yet oxygen keeps premature babies alive, and ROP still occurs at carefully controlled levels, because the underlying cause is a retina that was not ready to be born. Adjusting oxygen is the neonatologist’s job, balanced against the lungs and brain.

“The baby tracks my face, so the eyes are fine.” Tracking uses the central retina and can be intact while peripheral disease progresses. Only the dilated examination shows the retina.

“Glasses mean the treatment failed.” Nearsightedness after ROP is a known consequence, not a verdict on the procedure.

“Both eyes are always the same.” Disease is often asymmetrical. One eye may be treated and the other watched, and later vision may differ between them.

“Injection is the modern option, so it must be better.” Trials show a different recurrence pattern and different unanswered questions, not a clear winner. The right choice depends on the eye and the baby.

Questions to ask your care team after ROP treatment

A written list helps, because ward rounds move fast and the answers matter for weeks. These are the ones families most often wish they had asked sooner.

• Which zone and stage did each eye reach, and was there plus disease? Ask for it to be written down.
• Which treatment was used in each eye, and what was the reasoning?
• How long do you expect the lid swelling and redness to last for our baby, and what would make you want to see the eye sooner?
• What exactly do the drops or ointment do, and how many days will they continue?
• When is the next retinal examination, and how often after that?
• What would reactivation look like to you, and what would you do if you saw it?
• If we are discharged before surveillance ends, who arranges the outpatient exams, and what happens if we cannot attend one?
• Which signs should prompt us to call the same day rather than wait for the next appointment?
• At what age would you expect to first check for glasses or a squint?
• How does the eye team share information with the developmental follow-up team?
• Is there anything about our baby’s other conditions that changes the eye plan?
• Who do we contact at night or on a weekend if we are worried about the eyes?

Two further habits pay off. Ask for copies of the retinal photographs if the unit takes them; they help future clinicians and help parents see the change the team is describing. And ask the same question twice if the answer did not make sense the first time. Eye anatomy is hard, sleep deprivation is real, and good clinicians expect to repeat themselves.

When to call your doctor after ROP treatment

Most of what you see in the first days is expected. A short list of findings should prompt a same-day call to the neonatal unit or the eye team, whether the baby is still inpatient or has gone home.

• Eyelid swelling that worsens after the first day rather than easing, or a lid that becomes hot, hard or purple.
• Yellow or green discharge, or crusting that keeps returning after cleaning.
• A cornea, the clear front window of the eye, that looks cloudy, gray or hazy instead of glossy.
• A pupil that has become white or gray, or a change in the way light reflects from the eye.
• A baby who is inconsolable, arching or refusing feeds in a way that is new since the procedure.
• Fever, breathing changes or unusual sleepiness after anesthesia; these go to the neonatal team immediately.
• Bleeding on the surface that spreads rather than fades over days.
• Any missed follow-up examination. Call to rebook; do not wait for the next scheduled one.

Infection inside the eye after an injection is uncommon but can threaten sight within hours, which is why lid heat, discharge and a cloudy cornea are treated as emergencies rather than watch-and-wait findings. After a laser procedure, the main early concern is pressure rise inside the eye or excessive inflammation, both of which the team can measure and manage if told promptly.

Later in childhood, the red flags shift. A new squint, an eye that wanders, a child who tilts the head or holds objects unusually close, or one who covers or rubs one eye persistently should be raised with the pediatric ophthalmologist rather than waiting for the annual visit. Sudden new floaters, flashes or a curtain over the vision in an older child or teenager with an ROP history is an emergency, because it can signal a retinal tear.

Every judgment about whether a finding needs treatment, and what that treatment should be, rests with the team examining your child. This article can tell you what to watch for; it cannot look at the retina.

Frequently asked questions

What is considered severe ROP?

Severe ROP in practice means disease that meets the type 1 treatment threshold: any stage in zone I with plus disease, stage 3 in zone I without plus disease, or stage 2 or 3 in zone II with plus disease. Stage 4 and 5, meaning partial or total retinal detachment, are more severe still. Aggressive ROP, which progresses rapidly in the smallest babies, is also treated urgently.

When does ROP go away?

Most ROP regresses on its own as the retina matures, and treated ROP usually regresses over the weeks after laser or injection. Active disease can no longer begin once the retina has finished developing its blood supply. The team declares surveillance complete when they see stable regression, which happens sooner after laser than after anti-VEGF injection because late reactivation is possible with the latter.

Is ROP a disability?

ROP is a diagnosis, not a disability in itself; whether a child is considered disabled depends on the vision that remains. Many treated children see well with glasses, some have reduced vision in one eye, and a minority have low vision or blindness in both. Eligibility for support services depends on measured vision and local criteria rather than the ROP label.

How long does it take to fully recover from a detached retina in a baby?

The surgical wound heals over weeks, but a baby’s visual recovery is judged over years as the brain learns to use the reattached retina. Outcomes vary widely depending on whether the macula was involved and how much scar tissue formed. The surgeon can describe what they expect, but no one can promise a level of vision, and a second operation is sometimes needed.

How long does eye swelling last after ROP laser treatment recovery begins?

Eyelid swelling and redness after laser typically ease over the following days rather than weeks, but the range varies with the amount of laser applied and the baby’s tissue response. Your eye team will tell you the window they expect for your baby. Swelling that increases after the first day, or a lid that becomes hot and hard, should be reported the same day.

What does the ROP follow-up schedule look like after an anti-VEGF injection?

Examinations are usually weekly at first, then spaced out once the vessels are regressing, but surveillance continues longer than after laser. In the BEAT-ROP trial, recurrence after injection appeared at a mean of about 16 weeks, so teams keep examining until the retina has grown vessels to its edge or the baby is well past the age of reported reactivation.

Can ROP come back after treatment?

Yes, reactivation is possible after both laser and injection, which is the reason follow-up examinations continue. In BEAT-ROP, 26% of laser-treated eyes and 6% of injected eyes needed retreatment, with the injected eyes recurring later. Signs the examiner watches for are the return of plus disease, new vessel growth or new bleeding, all of which can be retreated if caught.

Will my baby need glasses after ROP treatment?

Many children treated for ROP become nearsighted, and glasses in the first two years are common, particularly after laser. Glasses do not mean the treatment failed; they give the developing brain a sharp image so vision can be wired normally. The pediatric ophthalmologist checks for refractive error and squint at set ages and will tell you when glasses are needed.

Does ROP laser treatment hurt the baby?

Laser is performed under general anesthesia or deep sedation, so the baby does not feel it during the procedure. Afterward, the eye can be sore and the lids swollen, which the neonatal team monitors using structured pain scores that combine facial expression, cry, body tension and vital signs. Comfort measures such as skin-to-skin holding, swaddling and low light help, and any pain relief is decided by the team.

Is an anti-VEGF injection for ROP safe for a premature baby?

Anti-VEGF drugs act inside the eye but small amounts enter the bloodstream, and the evidence on effects on a premature baby’s developing brain, lungs and other organs remains incomplete; some studies are reassuring and others raise unanswered questions. Serious eye infection after injection is rare. The treating team weighs these uncertainties against the zone of disease and the baby’s ability to tolerate anesthesia.

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.